Tower Research Capital LLC (Trc) Teva Pharmaceutical Industries LTD Transaction History

Tower Research Capital LLC (Trc)

  • $3.29 Billion
  • Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,531 shares of TEVA stock, worth $42,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,531
Previous 739 242.49%
Holding current value
$42,470
Previous $16,000 137.5%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$14.67 - $22.01 $26,288 - $39,441
1,792 Added 242.49%
2,531 $38,000
Q4 2024

Feb 13, 2025
SELL
$16.43 - $22.77 $474,498 - $657,597
-28,880 Reduced 97.5%
739 $16,000
Q3 2024

Nov 14, 2024
BUY
$15.81 - $18.96 $419,281 - $502,819
26,520 Added 855.76%
29,619 $533,000
Q2 2024

Aug 13, 2024
BUY
$12.78 - $17.4 $24,742 - $33,686
1,936 Added 166.47%
3,099 $50,000
Q1 2024

May 15, 2024
BUY
$10.67 - $14.43 $8,621 - $11,659
808 Added 227.61%
1,163 $16,000
Q4 2023

Feb 13, 2024
SELL
$8.12 - $10.63 $27,867 - $36,482
-3,432 Reduced 90.63%
355 $3,000
Q3 2023

Nov 14, 2023
BUY
$7.48 - $10.7 $26,778 - $38,306
3,580 Added 1729.47%
3,787 $38,000
Q2 2023

Aug 14, 2023
SELL
$7.2 - $9.47 $17,100 - $22,491
-2,375 Reduced 91.98%
207 $1,000
Q1 2023

May 09, 2023
BUY
$8.36 - $11.37 $3,795 - $5,161
454 Added 21.33%
2,582 $23,000
Q4 2022

Feb 10, 2023
SELL
$7.95 - $9.48 $10,692 - $12,750
-1,345 Reduced 38.73%
2,128 $19,000
Q3 2022

Nov 10, 2022
SELL
$6.86 - $11.95 $17,781 - $30,974
-2,592 Reduced 42.74%
3,473 $28,000
Q2 2022

Aug 15, 2022
SELL
$7.38 - $10.4 $104,840 - $147,742
-14,206 Reduced 70.08%
6,065 $46,000
Q1 2022

May 12, 2022
BUY
$7.33 - $9.39 $148,586 - $190,344
20,271 New
20,271 $190,000
Q4 2021

Feb 14, 2022
SELL
$7.9 - $10.19 $49,556 - $63,921
-6,273 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$8.38 - $10.18 $182,600 - $221,822
-21,790 Reduced 77.65%
6,273 $61,000
Q2 2021

Aug 16, 2021
BUY
$9.9 - $11.56 $150,311 - $175,515
15,183 Added 117.88%
28,063 $278,000
Q1 2021

May 17, 2021
SELL
$10.34 - $12.81 $327,705 - $405,987
-31,693 Reduced 71.1%
12,880 $148,000
Q4 2020

Feb 16, 2021
BUY
$8.61 - $11.04 $138,130 - $177,114
16,043 Added 56.23%
44,573 $430,000
Q3 2020

Nov 16, 2020
BUY
$8.57 - $12.69 $236,883 - $350,764
27,641 Added 3109.22%
28,530 $257,000
Q2 2020

Aug 13, 2020
SELL
$8.12 - $13.12 $168,303 - $271,938
-20,727 Reduced 95.89%
889 $11,000
Q1 2020

May 15, 2020
BUY
$6.69 - $13.45 $26,987 - $54,257
4,034 Added 22.94%
21,616 $194,000
Q4 2019

Feb 07, 2020
BUY
$6.53 - $10.72 $112,505 - $184,694
17,229 Added 4880.74%
17,582 $172,000
Q3 2019

Nov 05, 2019
BUY
$6.16 - $9.6 $2,174 - $3,388
353 New
353 $2,000
Q2 2019

Aug 13, 2019
SELL
$8.12 - $15.72 $64,594 - $125,052
-7,955 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$15.58 - $20.01 $468,085 - $601,180
-30,044 Reduced 79.07%
7,955 $125,000
Q4 2018

Feb 14, 2019
BUY
$14.59 - $23.84 $497,548 - $812,991
34,102 Added 875.08%
37,999 $586,000
Q3 2018

Nov 13, 2018
BUY
$21.06 - $25.65 $65,012 - $79,181
3,087 Added 381.11%
3,897 $84,000
Q2 2018

Aug 15, 2018
SELL
$16.77 - $24.71 $13,583 - $20,015
-810 Reduced 50.0%
810 $20,000
Q1 2018

May 15, 2018
BUY
$16.68 - $22.07 $23,819 - $31,515
1,428 Added 743.75%
1,620 $28,000
Q4 2017

Feb 09, 2018
BUY
$11.23 - $19.1 $2,156 - $3,667
192
192 $4,000

Others Institutions Holding TEVA

# of Institutions
660
Shares Held
626M
Call Options Held
27.9M
Put Options Held
21.8M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.6B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email